You are here: Industry Insights > AF

News List

NOACs May Be Better Choice for Patients With A-Fib and DM drugs.com
February 14, 2022
For patients with atrial fibrillation (AF) and diabetes mellitus (DM), non-vitamin K antagonist oral anticoagulants (NOACs) are associated...
NICE updates guideline on atrial fibrillation pharmatimes
April 28, 2021
The UK’s National Institute for Health and Care Excellence has published an updated clinical guideline on the diagnosis and management of atrial fibrillation (AF) addressing several areas of new evidence.
Daiichi Sankyo inks digital partnership for atrial fibrillation pharmatimes
March 24, 2021
Daiichi Sankyo has signed a collaborative agreement with three technology partners to improve the detection and diagnosis of atrial fibrillation (AF) in the UK.
Trial to Assess Pulsed Field Ablation System for AFib Receives FDA Conditional Approval americanpharmaceuticalreview
December 18, 2020
FARAPULSE announced the U.S. Food and Drug Administration (FDA) conditionally approved the Company's Investigational Device Exemption (IDE) application to initiate its U.S. pivotal ADVENT trial to evaluate the safety and effectiveness of its ...
Obesity Mediates Response to Antiarrhythmic Drugs in A-Fib drugs
December 18, 2019
Obesity may cause a differential response to antiarrhythmic drugs (AADs) used to suppress atrial fibrillation (AF), according to a study published online in JAMA Cardiology.
Having HIV May Heighten Stroke Risk drugs
September 10, 2019
People with HIV have a greatly increased risk of a common heart rhythm disorder that's a leading cause of stroke, a new study shows.
Anniversary of the pivotal RE-LY® trial marks a decade of innovation for stroke prevention in AF patients worldpharmanews
September 02, 2019
Boehringer Ingelheim today announces the ten-year anniversary of the RE-LY® trial publication(1-3) recognising the contribution made in the decade since by patients...
Correvio Resubmits Brinavess (vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation drugs
June 26, 2019
Correvio Resubmits Brinavess (vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation.
Risk Factors ID'd for Atrial Fibrillation With Type 1 Diabetes drugs
June 21, 2019
Risk Factors ID'd for Atrial Fibrillation With Type 1 Diabetes.
Catheter Ablation Tops Drug Therapy for A-Fib in Heart Failure drugs
January 02, 2019
Catheter ablation is better than drug therapy for the treatment of atrial fibrillation (AF) in patients with heart failure, according to a review published online Dec. 25 in the Annals of Internal Medicine.....

Previous page 1 2 Next page